Reviral

Scroll
Investment area
Novo Ventures
Region
Europe
Date of investment
July 2018
Website
https://www.reviral.co.uk/

ReViral is a UK-based biotechnology company with a portfolio of drugs to treat Respiratory Syncytial Virus (RSV) infection. RSV currently represents a major unmet medical need in children, the elderly and the immunocompromised.